v3.26.3
Related parties (Details 1)
₩ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2026
KRW (₩)
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
KRW (₩)
Dec. 31, 2024
KRW (₩)
IfrsStatementLineItems [Line Items]                
Beginning Balance | $   $ 84,669   $ 80,989 $ 80,989    
Increase | $   $ 80,989       3,680    
Decrease | $            
Ending Balance | $ 80,989 80,989       84,669    
CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance       ₩ 742,895     ₩ 264,245 ₩ 4,275,450
Increase       4,011,022     799,703 467,907
Decrease           321,053 4,479,112
Ending Balance       4,753,917     742,895 264,245
Total for all related parties [member] | Eun Jong Choi [Member] | Other Receivables [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance | $   52,918   50,618 50,618    
Increase | $ 50,618 [1]   1,140 [2],[3]     2,300 [4]    
Decrease | $          
Ending Balance | $ 50,618 50,618 54,058     52,918    
Total for all related parties [member] | Eun Jong Choi [Member] | Short term loan receivable [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance       140,000     140,000 600,000
Increase          
Decrease           460,000
Ending Balance       140,000     140,000 140,000
Total for all related parties [member] | Eun Jong Choi [Member] | Short term loan receivables [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance       36,035     29,595 6,338
Increase       3,194     6,440 23,257
Decrease          
Ending Balance       39,229     36,035 29,595
Total for all related parties [member] | CubeBio Co., Ltd. [Member] | Promissory Note Payables [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance | $   31,751   30,371 30,371    
Increase | $ 30,371 [5]       684 [6],[7] 1,380 [8]    
Decrease | $          
Ending Balance | $ $ 30,371 $ 30,371 $ 32,435   31,055 $ 31,751    
Total for all related parties [member] | CubeBio Holdings., Ltd. [Member] | Other Receivables [Member]                
IfrsStatementLineItems [Line Items]                
Ending Balance | $         $ 51,758      
Total for all related parties [member] | CubeBio Holdings., Ltd. [Member] | Short term loan receivable [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance       43,047     44,100
Increase       8,902     44,100
Decrease           1,053
Ending Balance       51,949     43,047 44,100
Total for all related parties [member] | CubeBio Holdings., Ltd. [Member] | Short term loan receivables [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance       2,517     550
Increase       1,393     1,967 550
Decrease          
Ending Balance       3,910     2,517 550
Total for all related parties [member] | Well core [Member] | Borrowing [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance            
Increase       1,000,000     270,000  
Decrease           270,000  
Ending Balance       1,000,000    
Total for all related parties [member] | Well core [Member] | Short term loan receivable [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance             309,112
Increase              
Decrease               309,112
Ending Balance              
Total for all related parties [member] | Well core [Member] | Short-term borrowings [member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance            
Increase               400,000
Decrease               400,000
Ending Balance              
Total for all related parties [member] | Well core [Member] | Accrued Expense [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance              
Increase       11,973        
Decrease              
Ending Balance       11,973      
Total for all related parties [member] | Dongsung D&C [Member] | Short term loan receivable [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance       220,000      
Increase       100,000     220,000  
Decrease            
Ending Balance       320,000     220,000
Total for all related parties [member] | Dongsung D&C [Member] | Short term loan receivables [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance       1,296      
Increase       5,560     1,296  
Decrease            
Ending Balance       6,856     1,296
Total for all related parties [member] | Dongsung D&C [Member] | Other payables advances received for allotment of common shares [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance [9]              
Increase [9]       1,280,000        
Decrease [9]              
Ending Balance [9]       1,280,000      
Total for all related parties [member] | Noh Bin Park [Member] | Bond with warrants [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance [10]       [11]     20,000 [11] 20,000
Increase [10]             [11]
Decrease [10]             20,000 [11]
Ending Balance [10],[11]             20,000
Total for all related parties [member] | Ho Sung Han [Member] | Bond with warrants [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance [10]       [11]     15,000 [11] 15,000
Increase [10]             [11]
Decrease [10]             15,000 [11]
Ending Balance [10],[11]             15,000
Total for all related parties [member] | Jung Gon Kim [Member] | Bond with warrants [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance [10]             2,400,000
Increase [10]              
Decrease [10]               2,400,000
Ending Balance [10]              
Total for all related parties [member] | Jung Gon Kim [Member] | Other Payables [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance       300,000 [12]     [10],[11]  
Increase       1,600,000 [12]     300,000 [10],[11]  
Decrease       [12]     [10],[11]  
Ending Balance       1,900,000 [12]     300,000 [12] [10],[11]
Total for all related parties [member] | Gyung Ha Yu [Member] | Bond with warrants [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance [10]       [11]     15,000 [11] 15,000
Increase [10]             [11]
Decrease [10]             15,000 [11]
Ending Balance [10],[11]             15,000
Total for all related parties [member] | Jae Myung Kim [Member] | Bond with warrants [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance [10]             700,000
Increase [10]              
Decrease [10]               700,000
Ending Balance [10]              
Total for all related parties [member] | Se Yoon Kim [Member] | Bond with warrants [Member] | CubeBio Co., Ltd. [Member]                
IfrsStatementLineItems [Line Items]                
Beginning Balance [10]             210,000
Increase [10]              
Decrease [10]               210,000
Ending Balance [10]              
[1] The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the period from September 24, 2024 (inception), through December 31, 2024.
[2] The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June 30, 2025.
[3] The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June 30, 2026.
[4] The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the year ended December 31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026.
[5] The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the period from September 24, 2024 (inception), through December 31, 2024.
[6] The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June 30, 2025.
[7] The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June 30, 2026.
[8] The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the year ended December 31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026.
[9] The Company received an advance payment of KRW 1,280,000 thousand from Dongsung D&C in connection with a planned investment, which was recorded within other payables as of June 30, 2026, as no shares had been issued. Subsequent to the reporting date, the transaction was finalized as a third-party allotment of common shares, under which the advance payment will be applied as share subscription proceeds (refer to Note 29).
[10] The amounts are presented in principal of bonds.
[11] The amounts are presented in principal of bonds.
[12] On November 4, 2025, the Company entered into an agreement with Jung Gon Kim to dispose of 1,000,000 treasury shares at KRW 3,000 per share, for total consideration of KRW 3,000,000 thousand. The Company received a down payment of KRW 300,000 thousand in the prior year and an interim payment of KRW 1,600,000 thousand during the six-month period ended June 30, 2026. As the shares had not been transferred as of June 30, 2026, the cumulative amount received of KRW 1,900,000 thousand was recorded as other payable.